UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057529 |
|---|---|
| Receipt number | R000065727 |
| Scientific Title | Transition of cancer survivors diagnosed with hereditary tumors |
| Date of disclosure of the study information | 2026/04/01 |
| Last modified on | 2025/04/06 10:52:03 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Transition of cancer survivors diagnosed with hereditary tumors
Acronym
Transition of cancer survivors diagnosed with hereditary tumors
Scientific Title
Transition of cancer survivors diagnosed with hereditary tumors
Scientific Title:Acronym
Transition of cancer survivors diagnosed with hereditary tumors
Region
| Japan |
Condition
Condition
Cancer
Classification by specialty
| Nursing |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Identify transitions of cancer survivors diagnosed with hereditary tumors
Basic objectives2
Others
Basic objectives -Others
Examine supports to promote psychological adjustment for cancer survivors diagnosed with hereditary tumors
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Non
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) The patient has been diagnosed with cancer and more than 4 months have passed since the completion of anticancer drug treatment, surgery, or radiation therapy.
2) The patient has been diagnosed with a hereditary tumor based on a genetic test or clinical diagnosis after being diagnosed with cancer, and it has been less than 6 years since the diagnosis of hereditary tumor.
3) The patient is able to speak Japanese and is aware that he/she is physically able to meet in person or online for a one-hour interview.
Key exclusion criteria
Non
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Satoko |
| Middle name | |
| Last name | MIYAWAKI |
Organization
University of Kochi
Division name
Doctoral Program
Zip code
7910280
Address
160 Minamiumemoto-cho Kou Matsuyama-Shi Ehime
TEL
09048947649
sattinlovesminmin@yahoo.co.jp
Public contact
Name of contact person
| 1st name | Satoko |
| Middle name | |
| Last name | MIYAWAKI |
Organization
Shikoku Cancer Center
Division name
Nursing-Dep
Zip code
7910280
Address
160 Minamiumemoto-cho Kou Matsuyama-Shi Ehime-pre
TEL
09048947649
Homepage URL
sattinlovesminmin@yahoo.co.jp
Sponsor or person
Institute
MIYAWAKI Satoko
Institute
Department
Personal name
Funding Source
Organization
Non
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
University of Kochi
Address
2751-1 Ike Kochi-shi KOCHI
Tel
088-847-8700
sattinlovesminmin@yahoo.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
18
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2022 | Year | 05 | Month | 26 | Day |
Date of IRB
| 2022 | Year | 04 | Month | 10 | Day |
Anticipated trial start date
| 2022 | Year | 06 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 20 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Interview
Management information
Registered date
| 2025 | Year | 04 | Month | 06 | Day |
Last modified on
| 2025 | Year | 04 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065727
